A unique revolutionary eco-friendly spectrophotometric technique for solving the spectral overlap in the determination of carvedilol and ivabradine in their binary combination: stability study

Author:

El Fiky Haitham A.ORCID,Abd El Ghany Maha F.,Badawey Amr M.,Fares N. V.,Ahmed Dina A.

Abstract

Abstract Background Carivalan® dosage form containing carvedilol and ivabradine is widely indicated for patients with stable angina. Three precise, eco-friendly and reproducible spectrophotometric techniques were created for resolving the researched drugs in their mixtures using zero and/or ratio spectra. Technique I is a factorized dual wavelength coupled with spectrum subtraction (FDW-SS), technique II is a ratio difference, and technique III is a constant center coupled with spectrum subtraction (CC-SS). Moreover, CAR and IVA were simultaneously determined in the existence of their oxidative degradation products exploiting the newly developed induced tripartite amplitude difference coupled with ratio subtraction (ITAD-RS) technique. Results The calibration curves for CAR and IVA showed linearity within 3.0–30.0 µg/ml, each. Techniques' precision, accuracy, and linearity ranges were resolved and validated in harmony with ICH guidelines. Additionally, the specificity was examined by examining created combinations of the proposed drugs with LOD of 0.258 and 0.290 for CAR, while for IVA 0.272 and 0.204. Conclusion These techniques were used to determine the presence of the provided drugs in Carivalan® tablets. There is statistical comparison between the found results of the offered spectrophotometric techniques and the previously reported ones with no discernible variance in the acquired results.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Reference33 articles.

1. Pharmacopoeia B (2022) British pharmacopoeia commission. London, TSO, UK, pp. 309–310. for Carvedilol, A-290

2. National Center for Biotechnology Information, (2022). PubChem compound summary for CID 2585, Carvedilol. https://pubchem.ncbi.nlm.nih.gov/compound/Carvedilol

3. National Center for Biotechnology Information, (2022). PubChem compound summary for CID 132999, Ivabradine. https://pubchem.ncbi.nlm.nih.gov/compound/Ivabradine

4. Sulfi S, Timmis AD (2006) Ivabradine–the first selective sinus node If channel inhibitor in the treatment of stable angina. Int J Clin Pract 60(2):222–228. https://doi.org/10.1111/j.1742-1241.2006.00817.x

5. Prajapati P, Naik K, Tailor P, Shah S (2022) Screening design and response surface methodology for the simultaneous estimation of carvedilol and ivabradine HCl by HPTLC method. J Chromatogr Sci 60(9):859–870. https://doi.org/10.1093/chromsci/bmab130

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3